Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Purple Biotech American Depositary Shares Representing 200 Ord Shs PPBT

Healthcare
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi... see more

Recent & Breaking News (NDAQ:PPBT)

Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack

GlobeNewswire May 2, 2019

Kitov Announces Key Milestone in FameWave Acquisition

GlobeNewswire April 12, 2019

FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)

GlobeNewswire April 12, 2019

FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)

GlobeNewswire April 12, 2019

Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company

GlobeNewswire March 14, 2019

Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update

GlobeNewswire February 7, 2019

Kitov Closes $6 Million Registered Direct Offering

GlobeNewswire January 18, 2019

Kitov Announces Pricing of $6 Million Registered Direct Offering

GlobeNewswire January 16, 2019

Thinking about buying stock in Aurora Cannabis Inc, Goodyear Tire & Rubber, Kitov Pharma, PG&E Corp or VirnetX?

PR Newswire January 16, 2019

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  January 16, 2019

New Data on Kitov’s NT219 Demonstrates its Unique Mechanism of Action and Anti-Cancer Effect

GlobeNewswire January 15, 2019

Mid-Afternoon Market Update: Dow Down 575 Points; OHR Pharmaceutical Shares Spike Higher

Benzinga.com  January 3, 2019

Mid-Day Market Update: Apple Falls On Lowered Sales Guidance; Kitov Pharma Shares Jum

Benzinga.com  January 3, 2019

Mid-Morning Market Update: Markets Open Lower; Bristol-Myers Squibb To Buy Celgene

Benzinga.com  January 3, 2019

26 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  January 3, 2019

Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensi™ in the U.S. with Coeptis Pharmaceuticals

GlobeNewswire January 3, 2019

The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut

Benzinga.com  October 19, 2018

The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs

Benzinga.com  October 18, 2018

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of American Depository Shares and Warrants of Kitov Pharmaceuticals Holdings, Ltd. -- KTOV

GlobeNewswire October 15, 2018

Kitov Appoints Gil Efron as Deputy Chief Executive Officer and Chief Financial Officer

GlobeNewswire October 11, 2018